WAYNE, Pa.--(BUSINESS WIRE)--Sep. 13, 2017--
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical
technologies for critical care, urology and surgery, will showcase the
product portfolio recently acquired from its new subsidiary, Vascular
Solutions, as well as its Arrow® Hemodialysis, Oncology and Peripheral
Intervention Solutions at the CIRSE Congress being held in Copenhagen,
Denmark, on September 16-20, 2017.
With the recent acquisition of Vascular Solutions, Teleflex now offers
clinical solutions for minimally invasive coronary and peripheral
vascular interventions, with a full line of products that give vascular
specialists the tools they need to handle routine and complex cases.
Clinicians worldwide rely on the quality and proven clinical utility of
products from Vascular Solutions, such as the Turnpike® Catheter,
Pronto® Extraction Catheter, Micro Elite™ Snare, Expro Elite™ Snare and
Hunter™ Biopsy Sealing Device.
The Arrow® OnControl® Powered Bone Access System offers the ability to
effectively, safely and rapidly obtain high quality bone samples.1,2,3,4
Our bone lesion biopsy needle is designed specifically for multiple bone
biopsies from a single cortical penetration. Using our patented handheld
driver technology, the Arrow® OnControl® Powered Bone Access System
provides interventional radiologists a fast, reliable solution for
accessing dense and hard-to-reach bone lesions.5
The ARROW-Clark™ VectorFlow™ Chronic Hemodialysis Catheter has an
innovative tip designed to produce a helical, three-dimensional
transition of blood entering and leaving the catheter.6
Designed for optimum performance, this tunneled hemodialysis catheter,
with symmetrical tip designed to reduce loss of lock solution7
(a contributing factor in reducing the risk of thrombus adherence8),
gives sustained high flows, minimizes recirculation and reduces the risk
of platelet damage resulting from shear stress.9
During the CIRSE Congress on Saturday, September 16, Teleflex is running
two “Central Lines and Ports” Hands-on Device Training Sessions
(CLP-HDT), featuring Timothy W.I. Clark MD (Director of Interventional
Radiology at Penn Presbyterian Medical Center, Associate Professor of
Clinical Radiology) and Alain Storms (Product Manager, Teleflex) as
presenters. CLP-HDT 1 will take place from 09:30-11:00 and CLP-HDT 2
will take place from 12:30-14:00, both in HDT Room 1.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to
improve the health and quality of people’s lives. We apply purpose
driven innovation – a relentless pursuit of identifying unmet clinical
needs – to benefit patients and healthcare providers. Our portfolio is
diverse, with solutions in the fields of vascular and interventional
access, surgical, anesthesia, cardiac care, urology, emergency medicine
and respiratory care. Teleflex employees worldwide are united in the
understanding that what we do every day makes a difference. For more
information, please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson
RCI®, LMA®, Pilling®, Rüsch®
and Weck® – trusted brands united by a common sense of
purpose.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
Teleflex, the Teleflex logo, Arrow, ARROW-Clark, Expro Elite,
Deknatel, Hudson RCI, Hunter, LMA, Micro Elite, OnControl, Pilling,
Pronto, Rüsch, Turnpike, VectorFlow, and Weck are trademarks or
registered trademarks of Teleflex Incorporated or its affiliates, in the
U.S. and/or other countries.
© 2017 Teleflex Incorporated.
All rights reserved.
References:
1. Berenson JR, Yellin O, Blumenstein B, et al. Using a powered bone
marrow biopsy system results in shorter procedures, causes less residual
pain to adult patients, and yields larger specimens. Diagnostic
Pathology 2011;6:23.*
2. Miller LJ, Philbeck TE, Montez DF, et al. Powered bone marrow biopsy
procedures produce larger core specimens, with less pain, in less time
than with standard manual devices. Hematology Reports
2011;3(e8):22-5. doi:10.4081/hr.2011.e8.* Available at: [PMC
free article] [PubMed]
verified March 2015.
3. Swords RT, Anguita J, Higgins RA, et al. A prospective randomized
study of a rotary powered device (OnControl) for bone marrow aspiration
and biopsy. J Clin Pathol 2011; 64(9):809-13.
doi:10.1136/jclinpath-2011-200047.*
4. Lee RK, Ng AW, Griffith JF. CT-guided bone biopsy with a
battery-powered drill system: preliminary results. AJR Am J Roentgenol
2013;201(5):1093-5. doi:10.2214/AJR.12.10521. Available at: [PubMed]
verified March 2015.
5. Symington K, et al. CT-guided biopsy produces high quality specimens
for diagnosis: a retrospective analysis of 64 consecutive cases using a
powered biopsy device at a community based hospital. Blood 2013;
122:5381.
6. Clark T, et al. Computational Flow Dynamics and Preclinical
Assessment of a Novel Hemodialysis Catheter. Seminars in Dialysis
2012;25(5):574-581. doi: 10.1111/j.1525-139X.2012.01052.*
7. Data on file at Teleflex. Compared to other competitive symmetrical
tip catheters.
8. http://www2.kidney.org/professionals/KDOQI/guideline_upHD_PD_VA/va_guide7.htm
9. Clark TWI, Isu G, Gallo D, Verdonck P, Morbiducci U. Comparison of
symmetric hemodialysis catheters using computational fluid dynamics. Journal
of Vascular and Interventional Radiology. 2015;26(2):252-259. doi:
10.1016/j.jvir.2014.11.004
* Research sponsored by Teleflex Incorporated.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170913005098/en/
Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836
or
Martina
Teichmann-Zindler
Senior Director Marketing Communications
International
+49 (0)7151-406-538
martina.teichmann@teleflex.com